La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cryo-Cell International a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cryo-Cell International..

Cryo-Cell International (AMEX:CCEL) Azioni, Catena delle Opzioni

Cryo-Cell International

CRYO-CELL INTL INC

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International Inc

CRYO-CELL International GAAP EPS of $0.07 beats by $0.13, revenue of $7.85M misses by $0.1M

Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more

CRYO-CELL International GAAP EPS of $0.08 beats by $0.04, revenue of $8M beats by $0.05M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Cryo-Cell International</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ccel-stock-quote/"><strong>CCEL</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Cryo-Cell International reported earnings per share of 8 cents. This was above the analyst estimate for EPS of 4 cents.</li><li>The company reported revenue of $8.04 million.</li><li>This was 1.17% better than the analyst estimate for revenue of $7.95 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/07/ccel-stock-earnings-cryo-cell-international-for-q2-of-2024/">CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024

In a report released yesterday, Allen Klee from Maxim Group assigned a Buy rating to Cryo-Cell International (CCEL – Research Report). The company'...

Maxim Group Gives a Buy Rating to Cryo-Cell International (CCEL)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Valneva (GB:0OB3 – Research Report), Sartorius Stedim Biotech (GB...

Analysts Offer Insights on Healthcare Companies: Valneva (GB:0OB3), Sartorius Stedim Biotech (GB:0RG8) and Cryo-Cell International (CCEL)

CRYO-CELL International declares $0.25 dividend

Cryo-Cell (CCEL) announced that its board of directors has approved the payment of a regular quarterly cash dividend at an initial rate of 25c per ...

Cryo-Cell initiates 25c per share quarterly dividend

09:40 EDT CRYO-CELL (CCEL) International, Inc. trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breakin...

CRYO-CELL International, Inc. trading resumes

09:30 EDT CRYO-CELL (CCEL) International, Inc. trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-ti...

CRYO-CELL International, Inc. trading halted, volatility trading pause

AFAR

AIRE

BSET

BSVN

BYRN

CCEL

EDUC

EPAC

ERIC

ETWO

EVGR

FAST

FNGR

GDST

HELE

HIFS

KRUS

LEDS

LEXX

MANU

NRIX

NTIC

NVOS

PCYO

PSMT

UPXI

VIST

VOXX

WDFC

XAIR

Press Releases

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

Accolade

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

ATI Physical Therapy, Inc. Class A Common Stock

ATI Physical Therapy

Biodesix

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Kindly MD

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Nutex Health

Ontrak

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Psychemedics

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

Cryo-Cell International

Cryo-Cell International (CCEL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO